Every Big Turn In GameStop Stock Price Followed Elliott Wave Patterns!
I have just published a detailed analysis of GameStop share price movements and you can view it at Forbes.com
Continue reading →I have just published a detailed analysis of GameStop share price movements and you can view it at Forbes.com
Continue reading →Elliott Waves is a trader’s best friend because it can help you identify and take low-risk trades. This post shows how Elliott Waves helped anticipate a 60% rally in Moderna (NASDAQ: MRNA). A client had approached me for a consultation in this stock around the end of December, and I had sent him the file…
Continue reading →I have just published an article on Forbes.com where I use Elliott Waves to determine a possible low-risk entry into Tesla (TSLA). Here is the link for that article. https://www.forbes.com/sites/greatspeculations/2021/01/12/a-low-risk-entry-into-tesla/
Continue reading →Happy New Year to all readers of WaveTimes! In order to be successful, you should spend a lot of time looking for the right candidates. Unfortunately, most traders spend a lot of time in the market, buying and selling stocks with very little to show in profits. Given the Elliott Wave edge that you now…
Continue reading →General Electric Co or GE has another 14% on the upside. This comes on the heels of a more-than-50% rally from the bottom that was discussed in WaveTimes back in June 2020. If you haven’t read that post, you will find that even as recently as 17 September, I had discussed GE’s fortunes. Take a…
Continue reading →Can we call the sideways consolidation in SNP500 a wave 4? You can observe that the SNP500 Index is in a sideways move while the markets are waiting for the final results of the 2020 US Presidential election. From an Elliott Wave perspective, can this be called a wave 4? This is the kind of…
Continue reading →General Electric (NYQ:GE) has rallied today by over 4.5%. But this rally was anticipated by Elliott Waves as far back as 22 June 2020. At that time, the stock was trading about the same levels as today, i.e. at $7.04. In an analysis shared with my member, I had suggested that we wait for a…
Continue reading →Acasti Pharma (NASDAQ:ACST) has been struggling to regain its levels seen last June. There were delays in releasing results for TRILOGY 2. But the announcement yesterday that a second Phase 3 clinical trial was unsuccessful resulted in Acasti Pharma shares collapse by over 60%. But this collapse was anticipated by Elliott Waves, although I was…
Continue reading →